Pooling analysis reveals that galectin‐1 is a reliable prognostic biomarker in various cancers
- 7 January 2019
- journal article
- research article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 234 (8) , 13788-13798
Abstract
Galectin‐1 is reported to be upregulated in various human cancers. However, the relationship between galectin‐1 expression and cancer prognosis has not been systematically assessed. In this study, we searched PubMed, Web of Science, and Embase to collect all relevant studies and a meta‐analysis was performed. We found that increased galectin‐1 expression was associated with tumor size (odds ratio [OR] = 1.75; 95% confidence interval [CI]: 1.06–2.89; p = 0.029), clinical stage (OR = 3.89; 95% CI: 2.40–6.31; p < 0.001), and poorer differentiation (OR = 1.39; 95% CI: 1.14–1.69; p = 0.001), but not with age (OR = 1.07; 95% CI: 0.82–1.39; p = 0.597), sex (OR = 0.89; 95% CI: 0.74–1.07; p = 0.202), or lymph node metastasis (OR = 2.57; 95% CI: 0.98–6.78; p = 0.056). In addition, we found that high galectin‐1 expression levels were associated with poor overall survival (HR = 2.12; 95% CI: 1.71–2.64; p < 0.001). The results were further validated using The Cancer Genome Atlas data set. Moreover, high galectin‐1 expression was significantly associated with disease‐free survival (hazard ratio [HR] = 1.60; 95% CI: 1.17–2.19; p = 0.003), progression‐free survival (HR = 1.93; 95% CI: 1.65–2.25; p < 0.001), and cancer‐specific survival (HR = 1.82; 95% CI: 1.30–2.55; p < 0.001). Our meta‐analysis demonstrated that galectin‐1 might be a useful common biomarker for predicting prognosis in patients with cancer.Keywords
Funding Information
- National Natural Science Foundation of China (31771665)
This publication has 52 references indexed in Scilit:
- Biomarkers in pre-eclampsia: A novel approach to early detection of the diseaseJournal of Obstetrics and Gynaecology, 2012
- Galectin-1 Secreted by Activated Stellate Cells in Pancreatic Ductal Adenocarcinoma Stroma Promotes Proliferation and Invasion of Pancreatic Cancer CellsPancreas, 2011
- Tumor Galectin-1 Mediates Tumor Growth and Metastasis through Regulation of T-Cell ApoptosisCancer Research, 2011
- Thiodigalactoside inhibits murine cancers by concurrently blocking effects of galectin-1 on immune dysregulation, angiogenesis and protection against oxidative stressAngiogenesis, 2011
- The Akt/mTOR Pathway Assures the Synthesis of HIF-1α Protein in a Glucose- and Reoxygenation-dependent Manner in Irradiated TumorsJournal of Biological Chemistry, 2009
- Presentation of Galectin-1 by Extracellular Matrix Triggers T Cell DeathJournal of Biological Chemistry, 2004
- Scatter-factor and semaphorin receptors: cell signalling for invasive growthNature Reviews Cancer, 2002
- Embryonic implantation in galectin 1/galectin 3 double mutant miceDevelopmental Dynamics, 1998
- Biphasic modulation of cell growth by recombinant human galectin-1Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1996
- Galectins: A family of animal β-galactoside-binding lectinsCell, 1994